Positive Airway Pressure Therapy for Sleep Apnea
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines adherence to two sleep apnea treatments: proactive CPAP (Continuous Positive Airway Pressure) and conventional APAP (Automatic Positive Airway Pressure) therapy. It aims to determine which method patients use more consistently over three months and one year, and whether differences in health outcomes, such as sleep quality and comfort, exist. The trial targets individuals newly diagnosed with moderate to severe obstructive sleep apnea who have not previously used PAP machines. As an unphased trial, it provides patients the opportunity to contribute to valuable research that could enhance future treatment options for sleep apnea.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the study doctor to understand how your medications might interact with the trial.
What prior data suggests that Positive Airway Pressure therapy is safe for sleep apnea patients?
Research shows that Continuous Positive Airway Pressure (CPAP) therapy is commonly used to treat obstructive sleep apnea (OSA). Studies indicate that most patients find CPAP comfortable. This treatment is already popular for OSA and other conditions, such as sudden heart-related lung issues, suggesting it is generally safe.
Proactive CPAP Therapy, a specific type of CPAP, is also considered safe and effective. Research found that most people using CPAP for sleep apnea had positive results without serious side effects.
Overall, both proactive and regular CPAP therapies appear to be safe options for treating sleep apnea, based on current research and their use in similar conditions.12345Why are researchers excited about this trial?
Researchers are excited about proactive CPAP therapy for sleep apnea because it offers a smarter approach to managing the condition. Unlike conventional APAP therapy, which adjusts air pressure only when breathing irregularities occur, proactive CPAP therapy anticipates these issues, adjusting the pressure in advance to prevent them. This proactive method aims to improve sleep quality and comfort, potentially leading to better adherence and outcomes for patients. By predicting and preventing breathing disruptions before they happen, this therapy could provide a more restful night's sleep for those suffering from sleep apnea.
What evidence suggests that this trial's treatments could be effective for sleep apnea?
Research has shown that Positive Airway Pressure (PAP) therapy effectively treats Obstructive Sleep Apnea (OSA). Studies have found that PAP can significantly enhance the quality of life for individuals with moderate to severe sleep apnea. Immediate benefits include normal breathing for 60% of users and fewer awakenings during sleep. Using PAP for at least four hours a night is associated with a lower risk of death. In this trial, participants will be assigned to different treatment arms. One arm will receive Proactive CPAP therapy, which involves patient participation and monitoring to improve adherence and overall sleep quality. Another arm will receive Conventional APAP therapy, serving as the control group.35678
Are You a Good Fit for This Trial?
This trial is for adults aged 18-70 who have just been diagnosed with moderate or severe Obstructive Sleep Apnea (OSA), meaning they have more than 15 breathing interruptions per hour of sleep. Participants should be able to follow the study's procedures and understand English. Those with uncontrolled, severe heart or brain conditions cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either proactive CPAP therapy or conventional APAP therapy for sleep apnea
Follow-up
Participants are monitored for adherence and health outcomes, with data collected by PAP device and self-reported questionnaires
Extension
Participants who are acceptant to therapy may continue for an additional 9 months
What Are the Treatments Tested in This Trial?
Interventions
- Conventional APAP Therapy
- Proactive CPAP Therapy
Conventional APAP Therapy is already approved in United States, European Union, Canada for the following indications:
- Obstructive Sleep Apnea (OSA)
- Obstructive Sleep Apnea (OSA)
- Obstructive Sleep Apnea (OSA)
Find a Clinic Near You
Who Is Running the Clinical Trial?
NovaResp Technologies Inc
Lead Sponsor